Jansen, J.W., Linneman, T.W., Tan, X. and Moenster, R.P. (2019) Comparison of Adverse Drug Reactions between Patients Treated with Ceftaroline or Ceftriaxone: A Single-Center, Matched Cohort Study. Open Forum Infectious Diseases, 6, ofz279.
https://doi.org/10.1093/ofid/ofz279

has been cited by the following article:

• TITLE: Leukocytoclastic Vasculitis Following Ceftriaxone Exposure

  AUTHORS: Alyssa Damstrom, Saira Khan, Urma Jalil, Eno-Obong Effiong, Michael Corti, Hanady Zainah

  KEYWORDS: Leukocytoclastic Vasculitis, Immune-Complex, Ceftriaxone, LCV

  JOURNAL NAME: Open Journal of Nephrology, Vol.12 No.2, June 30, 2022

  ABSTRACT: Leukocytoclastic vasculitis (LCV) is an immune-complex mediated inflammation of dermal capillaries and venules that can occur after infections, drugs, autoimmune disorders, neoplasms, or idiopathically. We present the case of a 59-year-old male who was treated with ceftriaxone for an abscess, S. aureus cellulitis, and osteomyelitis of his right second toe. Biopsy confirmed the diagnosis of LCV and symptoms resolved after ceftriaxone was discontinued and systemic corticosteroids were introduced.